KAT2B | K(lysine) acetyltransferase 2B | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
KAT6B | K(lysine) acetyltransferase 6B | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KMT2A | Lysine (K)-specific methyltransferase 2A | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
LCK | LCK proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
LIAS | Lipoic acid synthetase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
LPCAT1 | Lysophosphatidylcholine acyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LRTOMT | Leucine rich transmembrane and O-methyltransferase domain containing | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
LYN | LYN proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAP2K3 | Mitogen-activated protein kinase kinase 3 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
MAP2K4 | Mitogen-activated protein kinase kinase 4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MAP2K5 | Mitogen-activated protein kinase kinase 5 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
MAP2K6 | Mitogen-activated protein kinase kinase 6 | Cytoskeleton related proteins Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
MAP2K7 | Mitogen-activated protein kinase kinase 7 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MAP4K1 | Mitogen-activated protein kinase kinase kinase kinase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
MAP4K2 | Mitogen-activated protein kinase kinase kinase kinase 2 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK13 | Mitogen-activated protein kinase 13 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
MAPK3 | Mitogen-activated protein kinase 3 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK4 | Mitogen-activated protein kinase 4 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MAPK6 | Mitogen-activated protein kinase 6 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
MAPKAPK5 | Mitogen-activated protein kinase-activated protein kinase 5 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
MAT1A | Methionine adenosyltransferase I, alpha | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
MGAT4A | Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
MGST1 | Microsomal glutathione S-transferase 1 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
MKNK2 | MAP kinase interacting serine/threonine kinase 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
MYLK | Myosin light chain kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
NAA10 | N(alpha)-acetyltransferase 10, NatA catalytic subunit | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
NADK2 | NAD kinase 2, mitochondrial | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
NAGK | N-acetylglucosamine kinase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
NCOA1 | Nuclear receptor coactivator 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NCOA3 | Nuclear receptor coactivator 3 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NEK1 | NIMA-related kinase 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
NEK3 | NIMA-related kinase 3 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
NEK5 | NIMA-related kinase 5 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
NEK7 | NIMA-related kinase 7 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
NFS1 | NFS1 cysteine desulfurase | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
NME1 | NME/NM23 nucleoside diphosphate kinase 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
NME2 | NME/NM23 nucleoside diphosphate kinase 2 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
NME4 | NME/NM23 nucleoside diphosphate kinase 4 | Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
NMT1 | N-myristoyltransferase 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
NSUN2 | NOP2/Sun RNA methyltransferase family, member 2 | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
NTRK2 | Neurotrophic tyrosine kinase, receptor, type 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
NUS1 | Nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
OAT | Ornithine aminotransferase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |